AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
4
Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl
5
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
More news

Insight

6 stories about Insight
יניב ריבלין Yaniv Rivlin Bird Israel

Insights: Two years on, Bird reveals scope of Israel’s love affair with electric scooters

18.08.20|James Spiro
Company’s numbers find hundreds of thousands of Israelis are primarily using micro-mobility to bypass rush hour traffic jams
אבטחת סייבר 8.9.19 סטמפה

Top Israeli Startups 2020: Most Promising Cyber and Security Companies

28.04.20| Meir Orbach and Hagar Ravet
Using cutting edge home grown technology, these companies are doing their best to keep us safe at home and at work, even when it's the same place
אוריגמי לוג'יק עופר כהנא

Intuit Acquires Data Analytics Startup Origami Logic

29.05.19|Meir Orbach
Founded in 2011 by three Israeli serial tech entrepreneurs, Origami Logic offers market performance and market insight analytics to brands
צוות Spot.Im הייטקיסט

Social Engagement Startup Spot.IM Raises $25 Million

30.04.19|Meir Orbach
Spot.IM offers online publishers tools to create social communities and commenting platforms directly on their websites
מוסף 50 הסטארטאפים המבטיחים אפליקציית Factune של לייטריקס Lightricks

Facetune Developer Secures Additional Funding to Change How the World Creates Content

19.11.18|Meir Orbach
Jerusalem-based Lightricks completed a $60 million round, out of which $45 million will be used to buy stock off existing shareholders
חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials